Due to various effects of GPCR signaling downstream, RGS proteins have been implicated in a number of diseases, ranging from cancer to CNS disorders (Hishimoto et al., 2004; Lee & Tansey, 2015; Stuart Gibbons et al., 2008). This evidence concerns the gene PITX2 and cancer.